Argenx, Calliditas Hit The Ground Running After FDA Approvals
Green Lights For Vyvant and Tarpeyo
Two European companies - the Belgian-Dutch biotech Argenx and Calliditas of Sweden - are going it alone to commercialize their just-approved rare disease therapies in the US.
